Back to search results

Focused Orticumab Research for Treating Inflammation in Coronary Arteries

Abroad (travel likely)RecruitingPHASE2

Conditions

Acute Coronary Syndromes · Coronary Arterial Disease (CAD) · Inflammation · Heart Disease · Myocardial Infarct · Atherosclerotic Coronary Vascular Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Abcentra Investigational Site, Los Angeles, California, United States

  • Abcentra Investigational Site, Torrance, California, United States

  • Abcentra Investigational Site, Boca Raton, Florida, United States

  • Abcentra Investigational Site, Richmond, Indiana, United States

  • Abcentra Investigational Site, Louisville, Kentucky, United States

  • Abcentra Investigational Site, Baltimore, Maryland, United States

  • Abcentra Investigational Site, Midland, Michigan, United States

  • Abcentra Investigational Site, Ostrava, Moravian-Silesian Region, Czechia

  • Abcentra Investigational Site, Pilsen, Plzeň Region, Czechia

  • Abcentra Investigational Site, Prague, Praha 2, Czechia

  • Abcentra Investigational Site, Prague, Praha 4, Czechia

  • Abcentra Investigational Site, Brno, South Moravian, Czechia

  • Abcentra Investigational Site, Pécs, Baranya, Hungary

  • Abcentra Investigational Site, Budapest, Central Hungary, Hungary

  • Abcentra Investigational Site, Budapest, Central Hungary, Hungary

  • Abcentra Investigational Site, Budapest, Central Hungary, Hungary

  • Abcentra Investigational Site, Nyíregyháza, Szabolcs-Szatmár-Bereg, Hungary

  • Abcentra Investigational Site, Caserta, Campania, Italy

  • Abcentra Investigational Site, Ferrara, Ferrara, Italy

  • Abcentra Investigational Site, Brescia, Lombardy, Italy

  • Abcentra Investigational Site, Milan, Lombardy, Italy

  • Abcentra Investigational Site, Pavia, Lombardy, Italy

  • Abcentra Investigational Site, Krakow, Lesser Poland Voivodeship, Poland

  • Abcentra Investigational Site, Wroclaw, Lower Silesian Voivodeship, Poland

  • Abcentra Investigational Site, Warsaw, Masovian Voivodeship, Poland

  • Abcentra Investigational Site, Baia Mare, Maramureş, Romania

  • Abcentra Investigational Site, Târgu Mureş, Mureș County, Romania

  • Abcentra Investigational Site, Timișoara, Timiș County, Romania

  • Abcentra Investigational Site, Córdoba, Andalusia, Spain

  • Abcentra Investigational Site, Madrid, Madrid, Spain

  • Abcentra Investigational Site, Madrid, Madrid, Spain

  • Abcentra Investigational Site, El Palmar, Murcia, Spain

  • Abcentra Investigational Site, Seville, Sevilla, Spain

  • Abcentra Investigational Site, Danderyd, Stockholm County, Sweden

  • Abcentra Investigational Site, Solna, Stockholm County, Sweden

  • Abcentra Investigational Site, Gothenburg, Västra Götaland County, Sweden

  • Abcentra Investigational Site, London, Greater London, United Kingdom

  • Abcentra Investigational Site, Manchester, Greater Manchester, United Kingdom

  • Abcentra Investigational Site, Oxford, Oxfordshire, United Kingdom

  • Abcentra Investigational Site, Bath, Somerset, United Kingdom

  • Abcentra Investigational Site, Sheffield, South Yorkshire, United Kingdom

View source on ClinicalTrials.gov(opens in a new tab)